Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
Collaborator:
Central Norway Regional Health Authority
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00159549
First received: September 8, 2005
Last updated: November 18, 2005
Last verified: November 2005
  Purpose

A parallell group study comparing the effect of an education program with an education and training program for patients with COPD. 30 participants in each group. Participants self-select which group they wanted to be in. Main outcome is SGRQ (a HQoL for patients with COPD).


Condition Intervention Phase
Chronic Obstructive Pulmonary Disease
Behavioral: education and training program
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • St Geoprg Respiratory Questionnaire (SGRQ)

Secondary Outcome Measures:
  • COPD-Efficacy scale (Norwegian short version), Breathing Problems Questionnaire (BPQ), journal examinations, FVC, FEV1, six minutes walking test with registration of shortness of breath and pulseoxymetrical data.

Estimated Enrollment: 60
Study Start Date: January 2000
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients diagnosed with COPD (FEV1<75% of expected) who have the ability to conversation and active participation will be included.

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00159549

Locations
Norway
Department of Community Medicine and General Practice
Trondheim, Norway, N-7489
Sponsors and Collaborators
Norwegian University of Science and Technology
Central Norway Regional Health Authority
Investigators
Principal Investigator: Aslak Steinsbekk, PhD Norwegian University of Science and Technology
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00159549     History of Changes
Other Study ID Numbers: DMF 05/414
Study First Received: September 8, 2005
Last Updated: November 18, 2005
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Patient education

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 26, 2014